NRICM102

COMBINATION_PRODUCT2 trials

Sponsors

Taichung Veterans General Hospital, National Research Institute of Chinese Medicine, Ministry of Health and Welfare

Conditions

Antibiotic TherapyChronic Lower Respiratory DiseasesCommunity-Acquired Pneumonia (CAP)HospitalisationIntravenousMild to Moderate

Phase 2

Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia

Not yet recruitingNCT07583992

National Research Institute of Chinese Medicine, Ministry of Health and WelfareAntibiotic Therapy, Community-Acquired Pneumonia (CAP), Hospitalisation +2

Start: 2026-06-01End: 2027-11-01Target: 150Updated: 2026-05-13

Unknown Phase

Evaluation of the Safety and Clinical Efficacy of NRICM102 in Patients With Chronic Lower Respiratory Tract Diseases

Enrolling by invitationNCT06690203

Taichung Veterans General HospitalChronic Lower Respiratory Diseases

Start: 2024-09-30End: 2025-12-31Target: 70Updated: 2024-11-15